revolutionizing mm treatment with daratumumab
Published 6 years ago • 62 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
3:46
a phase ib/ii trial of sonrotoclax plus dexamethasone in patients with r/r mm harboring t(11;14)
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
2:42
final results of the dart4mm study of daratumumab for mrd eradication in myeloma
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
9:25
mgus diagnosis: a step-by-step approach
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma
-
6:47
al amyloidosis and a critical, early diagnosis
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
2:15
results of dreamm-4: safety and efficacy of belantamab mafodotin with pembrolizumab in r/r myeloma
-
3:12
real-world daratumumab monotherapy
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
2:46
the impact of daratumumab on the myeloma treatment landscape
-
4:13
daratumumab as maintenance therapy after autosct in patients with multiple myeloma
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
0:52
phase i study of ft538, an ipsc-derived nk cell therapy, with daratumumab in r/r multiple myeloma
-
2:17
session highlights: practical aspects of immunotherapy in multiple myeloma